Amylyx Pharmaceuticals EMEA B.V.
- Address
- Barbara Strozzilaan 201
Sponsor Overview
Specializations
Renal and hepatic impairment
Clinical research in volunteers with renal impairment and volunteers with hepatic impairment, alongside healthy volunteers, with a focus on how treatment exposure is affected by altered kidney and liver function.
- Renal function studies
- Hepatic function studies
- Healthy volunteer comparisons
The sponsor’s research activity is centred on understanding pharmacokinetic behavior in populations with compromised organ function.
Pharmacokinetics and drug disposition
Investigations are directed toward multiple-dose pharmacokinetic assessment, with attention to how AMX0035 is handled in participants with differing renal and hepatic status.
- Exposure assessment
- Organ impairment comparison
- Healthy participant reference groups
This area reflects interest in defining absorption, distribution, and elimination patterns relevant to special populations.
Special populations in clinical research
The sponsor funds studies involving participants with impaired renal function, participants with impaired hepatic function, and healthy participants, highlighting a therapeutic focus on population-specific evaluation.
- Impaired renal function
- Impaired hepatic function
- Healthy participants
These studies support clinical interest in how organ impairment may influence treatment handling across distinct participant groups.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Pharmacokinetic Evaluation of AMX0035 in Subjects with Hepatic Impairment and Healthy Controls |  Bulgaria | Not Recruiting |
| Pharmacokinetic Evaluation of AMX0035 in Subjects with Renal Impairment and Healthy Controls | Bulgaria | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 2 sites across their trial portfolio.
Therapeutic Focus
- 1.Not possible to specify2 trials220 other sponsors
Partnered Research Centres
2 centres- Address
- Ulitsa Urvich 13, Krasno Selo District, 1612 Sofia
- Address
- Georgi Kothcev Str 6, 5800 Pleven
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Amylyx Pharmaceuticals EMEA B.V..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.